Novo Nordisk A/S Common Stock (NVO)

Accounts Payable

kr 154.79B

Quarterly · Period ending: · DKK

NVO logo

NVO Accounts Payable

Latest reportedkr 154.79B DKK
NVO Quarterly Accounts Payable · DKK (kr 0.00 → kr 154.79B)
High-resolution chart · PNG

NVO accounts payable history

Quarterly · DKK. Dates are reporting period ends; fiscal years can differ from calendar years.

Novo Nordisk A/S Common Stock Accounts Payable — Quarterly (DKK)
Period endingAccounts Payable (DKK)
154,792,000,000
134,053,000,000
19,758,000,000
23,904,000,000
28,206,000,000
19,576,000,000
28,846,000,000
24,079,000,000
4,276,824,466
13,006,000,000
25,606,000,000
2,854,668,332
2,606,357,648
1,465,751,726
15,587,000,000
1,094,876,085
2,060,070,149
999,050,161
8,870,000,000
1,383,550,755
1,214,566,505
1,074,597,618
939,755,075
964,593,753
1,350,371,838
785,789,907
955,084,873
5,894,000,000
5,269,000,000
4,222,000,000
6,756,000,000
4,846,000,000
5,830,000,000
4,117,000,000
5,610,000,000
4,530,000,000
4,257,000,000
3,782,000,000
6,011,000,000
4,462,000,000
5,333,000,000
3,740,000,000
4,927,000,000
3,845,000,000
3,932,000,000
4,014,000,000
4,950,000,000
2,988,000,000
2,988,000,000
3,490,000,000
4,092,000,000
2,931,000,000
2,901,000,000
3,079,000,000
3,859,000,000
2,689,000,000
2,642,000,000
2,560,000,000
3,291,000,000
2,300,000,000
2,662,000,000
2,822,000,000
2,906,000,000
2,005,000,000
2,355,000,000
1,959,000,000
2,242,000,000
1,537,000,000
1,660,000,000
1,744,000,000
2,284,108,400
1,519,765,450
1,611,362,000
1,567,521,400
1,948,434,000
1,509,475,900
1,595,246,500
1,506,864,600
1,712,131,800
1,152,873,960
1,243,408,800
1,403,602,200
1,500,347,240
992,496,000
1,187,808,850
1,023,021,180
1,070,122,950
736,079,970
810,434,170
694,828,850
1,011,071,700
863,478,180
969,065,160
978,586,400
805,838,090
770,651,420
581,311,998
781,533,472
2,722,230,400
1,029,496,370
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.